ArticleJournal of clinical medicine2019

Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy.

Carsten Schmelter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.